Merck, Inc.

🇵🇭Philippines
Ownership
Subsidiary
Employees
-
Market Cap
$295.3B
Website
http://www.merck.ph
Clinical Trials
Related News

Sitagliptin Added-on to Insulin Study (0431-051)

Phase 3
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: sitagliptin phosphate
First Posted Date
2006-11-02
Last Posted Date
2017-05-12
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
641
Registration Number
NCT00395343

Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)

First Posted Date
2006-11-02
Last Posted Date
2015-07-16
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
311
Registration Number
NCT00394914

Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

Phase 2
Completed
Conditions
Chronic Hepatitis C
Interventions
Drug: NM283 plus Peg-IFNα-2a
First Posted Date
2006-11-02
Last Posted Date
2010-06-10
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
114
Registration Number
NCT00395421

Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)

First Posted Date
2006-11-01
Last Posted Date
2017-04-11
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
43
Registration Number
NCT00394589

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Phase 3
Completed
Conditions
Hepatitis B
First Posted Date
2006-10-27
Last Posted Date
2017-04-12
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1478
Registration Number
NCT00393523

Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea

First Posted Date
2006-10-26
Last Posted Date
2015-05-15
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
282
Registration Number
NCT00392574
Locations
🇺🇸

INC Research, New Hope, Pennsylvania, United States

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

First Posted Date
2006-10-25
Last Posted Date
2017-06-07
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
120
Registration Number
NCT00392171

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Phase 3
Completed
Conditions
Complicated Intra-Abdominal Infections
First Posted Date
2006-10-19
Last Posted Date
2017-02-17
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
300
Registration Number
NCT00389987

Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)

Phase 3
Completed
Conditions
Pain, Postoperative Arthroscopy
First Posted Date
2006-10-19
Last Posted Date
2017-02-02
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
420
Registration Number
NCT00390260

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain (MK-2295-005)

Phase 2
Completed
Conditions
Tooth Extraction
Pain, Postoperative
First Posted Date
2006-10-12
Last Posted Date
2015-11-01
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
89
Registration Number
NCT00387140
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy